The objective of this report is to examine the development of pharmacovigilance (PV) in Ghana and illustrate the role it plays in the health system, and more recently, during the COVID-19 emergency response...
This study examines the expenditure by Caribbean Community (CARICOM) countries on the delivery of Essential Public Health Services (EPHS), in the context of the global response to COVID-19. In particular...
This report discusses the importance of pharmacovigilance (PV) in contributing to building up resilient health systems. It is based on and summarizes the findings of a review of available literature on...
Building capacity in countries to conduct thorough surveillance of the use of all newly authorized drugs and vaccines, both brand name and generic, is a critical “public good” investment to ensure that...
Medicines, vaccines, medical devices, and blood are commonly used to treat disease. Medicines deserve a special focus because almost any medical visit ends with at least one prescription. So, monitoring...
This report focuses on the Caribbean Public Health Agency (CARPHA), one of the three multi-national public health agencies in the world, that commenced operations on Jan 1, 2013, with the aim of delivering...
The Spanish System of Pharmacovigilance (SSPV) started its activities almost 40 years ago, in 1985. Of particular interest to others considering various options for developing pharmacovigilance systems...
Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh...
The response of the government of the Republic of Korea to COVID-19 has been heralded as among the most successful. In the first two years of the pandemic, the government was able to keep the size of the...
The ability to oversee and monitor the use of all newly authorized drugs and vaccines, both brand name and generic, is critical to ensure that they work correctly and that their health benefits outweigh...
This report reviews the pharmacovigilance system of the European Union (EU) mapping out its structure and processes with any eye to features that may be of particular interest to decision makers in other...
Health care workers (HCWs) face disproportionate risk of exposure and becoming ill in any infectious disease outbreak. SARS-CoV-2 has proven to be no exception: From Wuhan to Manaus, London to Tehran...
Purchasing for health, which includes what, how, and from whom services are purchased, was one of the policy levers available to countries as part of their health systems’ response to the COVID-19 pandemic...
The main purpose of this Guiding Framework document is to present the key elements of a Nutrition Public Expenditure Review (NPER) and offer guidance, practical steps, and examples on carrying out an NPER...
The world has waited long enough for high-performing primary health care (PHC). It’s time to deliver. Forty years ago, leaders embraced the promise of health for all through PHC. That vision has inspired...
Achieving universal health coverage (UHC) is a top global priority, and nutrition actions are a critical part of meeting that goal. When delivered within key windows of opportunity to improve health throughout...
Achieving universal health coverage (UHC) is a top global priority, and nutrition actions are a critical part of meeting that goal. When delivered within key windows of opportunity to improve health throughout...
This paper examines how political priority was generated for comprehensive reforms to address inequitable access to high-quality primary health care (PHC) in Romania. We apply John Kingdon’s model of political...